We determined muscle fi ber type -specifi c hypertrophy and changes in satellite cell (SC) content following a 12-week resistance training program in 13 healthy, elderly men (72 ± 2 years). Leg strength and body composition (dual-energy X-ray absorptiometry and computed tomography) were assessed, and muscle biopsy samples were collected. Leg strength increased 25% -30% after training ( p < .001). Leg lean mass and quadriceps cross-sectional area increased 6% -9% ( p < .001). At baseline, mean fi ber area and SC content were smaller in the Type II versus Type I muscle fi bers ( p < .01). Following training, Type II muscle fi ber area increased from 5,438 ± 319 to 6,982 ± 503 m m 2 ( p < .01). Type II muscle fi ber SC content increased from 0.048 ± 0.003 to 0.084 ± 0.008 SCs per fi ber ( p < .001). No changes were observed in the Type I muscle fi bers. In older adults, skeletal muscle tissue is still capable of inducing SC proliferation and differentiation , resulting in Type II muscle fi ber hypertrophy .
S
ARCOPENIA is defi ned as the gradual decline in skeletal muscle mass and strength with aging. On a myocellular level, sarcopenia is characterized by a reduction in the number of both Type I and II muscle fi bers ( 1 ) and specifi c Type II muscle fi ber atrophy ( 1 -4 ) . In skeletal muscle tissue, satellite cells (SCs) are essential for myofi ber repair, maintenance, and growth ( 5 -8 ) . As such, an age-related decline in SC number and/or function could have an important role in the etiology of sarcopenia. Previous studies have either shown a similar ( 2 , 9 -11 ) or lower ( 12 , 13 ) SC content in older adults when compared with young adults. Recently, we reported that Type II muscle fi ber atrophy in older adults is associated with a specifi c decline in Type II muscle fi ber SC content ( 4 ) . The latter likely explains the discrepant fi ndings in previous studies that only assessed SC content in mixed muscle tissue.
Resistance type exercise training has been shown to represent an effective interventional strategy to augment muscle mass, strength, and function in older adults ( 14 -19 ) . Previous studies in older adults have shown that the muscle adaptive response to resistance training is characterized by Type II muscle fi ber hypertrophy ( 16 -19 ) . For muscle fi ber hypertrophy to occur beyond a certain threshold, the addition of new myonuclei is essential. The latter is facilitated by the proliferation of SCs and the differentiation of their progeny into new myonuclei that fuse with existing muscle fi bers ( 7 , 8 , 20 ) . Though the exact signaling pathways leading to muscle hypertrophy following resistance type exercise remain to be elucidated, it seems evident that an increase in the number of SCs is needed to allow the muscle adaptive response to occur. In accordance, some studies ( 21 , 22 ) have reported an upregulation of the number of SCs in mixed muscle tissue following exercise training in older adults. However, others have failed to confi rm these fi ndings ( 9 , 23 ) . The apparent discrepancy in the literature is likely attributed to the lack of fi ber type -specifi c data on this topic. We hypothesized that resistance type exercise training in older adults increases SC content in a fi ber type -specifi c manner, thereby allowing Type II muscle fi ber hypertrophy.
The present study aims to assess the impact of a 3-month resistance type exercise training program on muscle strength, body composition, and muscle fi ber type -specifi c characteristics in healthy, elderly men. Skeletal muscle biopsies were collected before and after completion of the exercise intervention program to determine the impact of resistance type exercise training on muscle fi ber type -specifi c hypertrophy, myonuclei, and SC content in older adults.
Methods

Participants
A total of 14 healthy elderly men (aged 65 -85 years) volunteered to participate in a 12-week resistance type exercise intervention program (three sessions per week). One participant dropped out during the study because of an acute back problem that occurred during gardening. Medical history of all participants was evaluated, and an oral glucose tolerance test (OGTT) and resting electrocardiogram were ( 24 ) . The latter was used as an exclusion criterion as insulin resistance and/or type 2 diabetes can strongly affect the process of muscle mass loss with aging ( 25 ) . All participants were living independently and had not participated in any structured exercise training program over the past 5 y. All participants were informed on the nature and possible risks of the experimental procedures, before written informed consent was obtained. All procedures were performed according to the Declaration of Helsinki, and the study was approved by the Medical Ethics Committee of the Academic Hospital, Maastricht, the Netherlands. This study is part of a greater project investigating the clinical benefi ts of exercise intervention in older adults.
Study Design
After screening, all eligible participants were enrolled in a 12-week resistance type exercise intervention program. Before, during, and after the exercise intervention, anthropometric measurements (height, body mass, leg volume) ( 26 ) , strength assessments, and computed tomography (CT) and dual-energy X-ray absorptiometry (DEXA) scans were performed and muscle biopsies, blood samples, and dietary intake records were collected.
Dietary Intake and Physical Activity Standardization
Standardized meals ( ~ 4.0 MJ: 57 Energy% [En%] carbohydrate, 30 En% fat, and 13 En% protein) were provided to all participants prior to each test day, and participants were instructed to refrain from strenuous physical activity for 3 days prior to testing. Dietary intake was recorded for 2 days prior to muscle biopsy and blood sample collection. These records were used to standardize food intake prior to muscle biopsy and blood sampling 4 days after cessation of the exercise intervention program. On all test days, participants arrived at the laboratory by car or public transportation, following an overnight fast. The latter was confi rmed by dietary intake records and further verifi ed by the assessment of basal blood glucose and insulin concentrations and blood lipid profi le. To assess potential changes in daily food intake that might have occurred during the intervention period, participants recorded 3-day weighted dietary records (Thursday to Saturday), prior to the onset of the intervention program and in Week 11 of the exercise intervention. Food intake records were analyzed with Eetmeter software 2005, version 1.4.0 (Voedingscentrum, the Hague, the Netherlands).
Strength Assessment
Maximum strength was assessed by means of one-repetition maximum (1RM) strength tests on regular leg press (LP) and leg extension (LE) machines (Technogym, Rotterdam, the Netherlands). During a familiarization trial, a proper lifting technique was demonstrated and practiced and maximum strength was estimated using the multiple-repetitions testing procedure ( 27 ) . In an additional session, at least 1 week before muscle biopsy collection, each participant's 1RM was determined as described previously ( 4 ) . The 1RM tests were repeated following 4 and 8 weeks of intervention and after cessation of the intervention program, 2 days after the last exercise session.
Exercise Intervention Program
Supervised resistance type exercise training was performed three times a week for a period of 12 weeks. Training consisted of 5 minutes of warming-up on a cycle ergometer, followed by four sets on both the LP and LE machines, and a 5-minute cooling-down period on the cycle ergometer. During the fi rst 4 weeks of training, the workload was increased from 60% of 1RM (10 -15 repetitions in each set) to 75% of 1RM (8 -10 repetitions). Starting at Week 5, four sets of eight repetitions were performed at 75% -80% of 1RM on each machine. Resting periods of 1.5 and 3 minutes were allowed between sets and exercises, respectively. Workload intensity was adjusted based on the 1RM tests (Weeks 4 and 8). In addition, workload was increased if more than eight repetitions could be performed in three out of four sets. Exercise sessions were always performed in the morning, at the same time of day. Participants had breakfast 1.5 hours before each exercise session, and lunch 2 hours after each session. On average, participants attended 35 ± 1 of the 36 scheduled exercise sessions.
CT Scans
Anatomical cross-sectional area (CSA) of the quadriceps muscle was measured with a CT scanner (IDT 8000; Philips Medical Systems, Best, the Netherlands) prior to and after cessation of the exercise intervention program (3 days after strength assessment and prior to muscle biopsy collection). With participants lying supine, legs extended, and their feet secured, a 3-mm-thick axial image (scanning characteristics: 120 kV, 300 mA, rotation time of 0.75 seconds, and fi eld of view of 500 mm) was taken midway between the anterior superior iliac spine and the bottom of the patella. The exact scanning position was measured and marked, to be replicated after cessation of the intervention program. Using the described approach we determined the coeffi cient of variation for repeated scans to be 0.6%. Images were loaded onto a PC using AGFA IMPAX imaging software, version 5.2 (AGFA Healthcare , Brussels, Belgium). Muscle area of the right leg was selected between − 29 and +150 Hounsfi eld units ( 28 ) , after which the quadriceps muscle was selected by manual tracing. Quadriceps CSA was calculated using Lucia 4.81 software (Nikon Instruments Europe, Badhoevedorp, the Netherlands). All analyses were performed by two investigators blinded to participant coding; intraclass correlation coeffi cients for inter-and intrainvestigator reliability were 0.997 and 0.998, respectively.
DEXA Scans
Directly after CT scanning, body composition and bone mineral content were measured with DEXA (Lunar Prodigy Advance; GE Healthcare, Madison, WI). Whole-body and regional lean mass, fat mass, and bone mineral content were determined using the system's software package enCORE 2005 (version 9.15.00 ); GE Healthcare.
Blood Samples
To determine glucose homeostasis and exclude insulinresistant participants and/or participants with diabetes, fasting blood samples were collected prior to the intervention, and 4 days after the strength assessment was performed after completion of the exercise program. Blood samples were collected in ethylenediaminetetraacetic acid (EDTA) -containing tubes and centrifuged at 1,000 g and 4°C for 10 minutes. Aliquots of plasma were frozen in liquid nitrogen and stored at − 80°C. Plasma samples were analyzed for glucose (COBAS FARA, Uni Kit III; Roche, Basel, Switzerland) and insulin concentrations (Insulin RIA Kit; LINCO Research Inc., St Charles, MO). Blood HbA1c content (3-mL blood sample, EDTA) was analyzed by highperformance liquid chromatography (Bio-Rad Variant II; Bio-Rad , Munich, Germany). Plasma glucose and insulin concentrations from the OGTT were used to estimate wholebody insulin sensitivity using the oral glucose insulin sensitivity index ( 29 ) .
Muscle Biopsies
Three days prior to the onset of exercise training and 4 days after the postintervention strength assessment, muscle biopsy samples were taken from the right leg of each participant, in the morning after an overnight fast. After local anesthesia, percutaneous needle biopsies (50 -80 mg) were taken from the vastus lateralis muscle, ~ 15 cm above the patella ( 30 ) . The posttraining biopsy was performed ~ 1 cm proximal to the pretraining biopsy, at the same depth. Any visible nonmuscle tissue was removed from the biopsy samples, which were then embedded in Tissue-Tek (Sakura Finetek, Zoeterwoude, the Netherlands), immediately frozen in liquid nitrogen -cooled isopentane, and stored at -80°C until further analyses.
Immunohistochemistry
From all biopsies, 5-m m-thick cryosections were cut at -20°C. Pre-and postintervention samples from one participant were mounted together on uncoated glass slides. Care was taken to properly align the samples for cross-sectional fi ber analyses. Serial cross-sections were stained for muscle fi ber typing (FT) and myocellular SC content as described previously ( 4 , 31 ) . First antibodies used are directed against myosin heavy chain (MHC)-I (A4.951, dilution 1:20; Developmental Studies Hybridoma Bank, Iowa City, IA), laminin (polyclonal rabbit anti-laminin, dilution 1:50; Sigma, Zwijndrecht, the Netherlands), and CD56 (dilution 1:40; BD Biosciences, San Jose, CA). The latter antibody has been extensively used for SC determination in human muscle tissue ( 2 , 12 , 21 , 23 , 32 , 33 ) . Appropriate secondary antibodies were applied: goat anti-mouse IgG1 AlexaFluor488 and goat anti-rabbit IgG AlexaFluor555 (dilution 1:500 and 1:200; Molecular Probes, Invitrogen, Breda, the Netherlands, respectively) and Avidin-D (dilution 1:333; Vector Laboratories, Inc., Burlingame, CA), respectively. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI, 0.238 m M; Molecular Probes). Staining procedures were as follows. After fi xation (5 minutes acetone), slides were airdried and incubated for 60 minutes at room temperature with primary antibodies directed against laminin and either MHC-I or CD56, diluted in 0.05% Tween -phosphate-buffered saline (PBS). Slides were then washed (3 × 5 minutes PBS). Slides for FT were then incubated for 30 minutes at room temperature with the appropriate secondary antibodies, diluted together with DAPI in 0.05% Tween-PBS. For optimizing the staining result, slides for SCs were fi rst incubated for 30 minutes with biotinylated horse anti-mouse IgG (dilution 1:150; Vector Laboratories, Inc.), diluted in PBS. After another washing step with PBS, SC slides were then incubated for 10 minutes with the secondary antibodies, diluted together with DAPI in 0.05% Tween-PBS. After a fi nal washing step, all slides were mounted with cover glasses using Mowiol (Calbiochem, Amsterdam, the Netherlands). Staining procedures resulted in laminin stained in red, nuclei in blue, and either MHC-I or CD56 in green ( Figure 1 ).
All images were digitally captured, using fl uorescence microscopy with a Nikon E800 fl uorescence microscope (Nikon Instruments Europe) coupled to a Basler A113 C progressive scan color CCD camera with a Bayer color fi lter. Epifl uorescence signal was recorded using a Texas Red excitation fi lter (540 -580 nm) for laminin, a DAPI UV excitation fi lter (340 -380 nm) for the nuclei, and a fl uorescein isothiocyanate excitation fi lter (465 -495 nm) for either MHC-I or CD56. Image processing and quantitative analyses were done using Lucia 4.81 software package , as described previously ( 4 ). All image recordings and analyses were performed by an investigator blinded to participant coding.
From the FT slides, images were captured at a 120× magnifi cation. Laminin was used to determine the basement membrane, and all fi bers within each image were identifi ed as Type I or Type II fi ber ( Figure 1 ). Within each image, the number of fi bers, the mean fi ber cross-sectional area (CSA ), the number of myonuclei per fi ber, and the mean fi ber area per myonucleus (fi ber CSA/no. of myonuclei) were measured for the Type I and Type II muscle fi bers separately. To obtain the true number of myonuclei (ie, not SC nuclei), the number of nuclei was corrected for the number of SCs counted on the SC slides. Fiber circularity was calculated as (4 p ·CSA)/(perimeter) 2 ; all fi bers with circularity below 0.60 were excluded from analysis ( 17 ) . No differences in fi ber circularity were observed over time or between fi ber types, validating the comparison of pre-and posttraining data on muscle fi ber CSA.
From the SC slides, images were captured at a 240× magnifi cation to allow clear determination of SC localization. Laminin was used to visualize cell borders. FT was determined by matching the serial FT slides. SCs were determined at the periphery of each fi ber and stained positive for both DNA (DAPI) and CD56 ( Figure 1 ). The number of SCs per muscle fi ber, the percentage of SCs [no. of SCs/(no. of SCs + no. of myonuclei) × 100], and the number of SCs per fi ber area (in square millimeters) were calculated for the Type I and Type II muscle fi bers separately. A mean total of 328 ± 31 and 254 ± 37 muscle fi bers were analyzed in each participants ' pre-and postintervention biopsy sample, respectively.
Statistics
All data are expressed as means ± SEMs. Differences between pre-and postintervention values were analyzed with Student's paired t tests. In addition, two-way repeated measures analysis of variance with time (pre vs post) and fi ber type (Type I vs Type II) as within-participants factors was used to determine training-induced changes in muscle fi ber type -specifi c variables. In case of signifi cant interaction, Student's paired t tests were performed for time effects within Type I or Type II muscle fi ber characteristics, and/or effects of muscle fi ber type within the pre-or postintervention values. All analyses were performed using SPSS version 13.0 (SPSS, Chicago, IL). An a -level of 0.05 was used to determine statistical signifi cance.
Results
Participants
Participants ' characteristics at baseline and after intervention are provided in Table 1 . Participants ' age averaged 72 ± 2 years. Total body mass, height, and body mass index did not change over the intervention period. Fasting blood glucose and insulin concentrations and HbA1c contents were within normal range for healthy individuals and did not change over time ( Table 1 ) .
Muscle Strength
Strength (1RM) increased signifi cantly from pre-to postintervention for both the LE and LP exercises, from 88 ± 4 to 111 ± 5 kg and from 170 ± 8 to 210 ± 10 kg, respectively ( p < .001). Repeated measures analysis revealed that the increase in 1RM strength was statistically significant for each 4-week interval during the intervention period for both exercises (data not shown).
Body Composition and Muscle Mass
Whole-body lean mass tended to increase throughout the intervention period (from 57.4 ± 1.6 to 58.0 ± 1.7 kg; p = .062). Total fat mass decreased signifi cantly ( p < .01), resulting in a signifi cant decline in whole-body fat percentage ( p < .01; Table 2 ). Leg lean mass increased from 18.3 ± 0.5 to 19.3 ± 0.5 kg ( p < .001). In accordance, fat percentage in the legs had also decreased following the exercise intervention ( p < .05; Table 2 ). No changes were observed in whole-body and regional bone mineral content (data not shown).
CT scans of the upper leg, performed prior to and after the exercise program, revealed a substantial 8.8% ± 1.4% increase in quadriceps ' anatomical CSA following the intervention program, from 75.9 ± 3.7 to 82.4 ± 3.9 cm 2 ( p < .001). 
Dietary Records
Analysis of the 3-day dietary records before and after 11 weeks of intervention did not show any changes in total daily energy intake (9.2 ± 0.6 vs 9.1 ± 0.4 MJ/day, respectively). Likewise, macronutrient composition of the diet did not change during the intervention period, and averaged 50 ± 2, 33 ± 2, and 17 ± 1 En% before intervention and 52 ± 2, 32 ± 2, and 16 ± 1 En% after 11 weeks of intervention, for carbohydrate, fat, and protein, respectively. Daily protein intake averaged 1.1 ± 0.1 g/kg body mass/day, both before and after 11 weeks of intervention.
Muscle Fiber Type Composition and Fiber Area
At baseline, the proportion of Type I and Type II muscle fi bers was 47% ± 4% and 53% ± 4%, and the proportion of muscle area occupied by Type I and II fi bers was 52% ± 4% and 48% ± 4%, respectively. Muscle fi ber type percentage, expressed either as fi ber number or area occupied by Type I and Type II muscle fi bers, did not show any changes following 3 months of exercise intervention ( Table 3 ) .
For muscle fi ber CSA, a signifi cant " Time × Fiber type " interaction was observed. At baseline, Type II muscle fi ber CSA was smaller than Type I muscle fi ber CSA ( Table 3 , p < .01). However, the difference in fi ber type CSA was no longer apparent after the intervention period, with a mean Type I and II muscle fi ber CSA of 6,881 ± 493 and 6,982 ± 503 m m 2 , respectively ( Table 3 ) . In contrast to the Type I fi bers, Type II muscle fi ber CSA signifi cantly increased following exercise intervention from 5,438 ± 319 to 6,982 ± 503 m m 2 ( p < .01).
Myonuclear and SC Content
At baseline, the number of myonuclei per muscle fi ber was higher in the Type I versus Type II muscle fi bers (3.6 ± 0.2 vs 2.8 ± 0.2, respectively; p < .01). A signifi cant Time × Fiber type interaction revealed that after the exercise intervention, differences in myonuclear content were no longer apparent between the Type I and II muscle fi bers (3.4 ± 0.3 vs 3.3 ± 0.8, respectively). In contrast to the Type I fi bers, the number of myonuclei per Type II muscle fi ber tended to increase from 2.8 ± 0.2 to 3.3 ± 0.3 during the intervention program ( p = .091). Mean fi ber area per myonucleus was similar for the Type I and II muscle fi bers at baseline and did not change over time ( Table 4 ) .
For all SC variables, signifi cant Time × Fiber type interactions were observed. The number of SCs per muscle fi ber at baseline was lower for the Type II fi bers compared with the Type I fi bers (0.048 ± 0.003 vs 0.089 ± 0.006, respectively; p < .001). For the percentage of SCs and the number of SCs per square millimeter, analysis also revealed a signifi cantly lower SC content in the Type II versus Type I fibers at baseline ( Table 4 ). In contrast to the Type I muscle fi bers, signifi cant increases were observed in the Type II muscle fi ber SC content after 3 months of exercise intervention ( Figure 2 , Table 4 ). The number of SCs per Type II muscle fi ber increased substantially from 0.048 ± 0.003 to 0.084 ± 0.008 ( p < .001), the percentage of SC increased from 1.8 ± 0.1 to 2.6 ± 0.3 ( p < .01), and the number of SCs per square millimeter of Type II fi ber area increased from 9.2 ± 0.8 to 11.9 ± 0.9 ( p < .01). In accordance, after the intervention program, no differences in SC content were observed between the Type I and II muscle fi bers for any of the SC variables ( Figure 2 , Table 4 ) .
Discussion
The present study shows that 3 months of resistance type exercise training augments muscle mass, reduces fat mass, and increases muscle strength in healthy, elderly men. The observed skeletal muscle hypertrophy is shown to be specifi c for the Type II muscle fi bers and accompanied by a specifi c increase in Type II muscle fi ber SC content.
Aging is associated with the loss of muscle mass, strength, and functional capacity ( 34 -36 ) . It has been well established that resistance type exercise training represents a feasible and effective interventional strategy to counteract sarcopenia in various elderly populations ( 14 -19 , 21 , 22 , 34 , 37 , 38 ) . The resistance exercise program implemented in the present study was shown to be feasible, and resulted in a high compliance and adherence rate, with 35 ± 1 out of 36 75.9 ± 3.7 82.4 ± 3.9 * Notes: Data are means ± SEMs; CSA, cross-sectional area of the right quadriceps muscle.
* Signifi cantly different compared with before the intervention ( p < .05). Notes: Data are means ± SEMs; CSA: fi ber cross-sectional area; CSA%: percentage area occupied by muscle fi ber type. * Signifi cantly different compared with the Type I muscle fi bers ( p < .01). † Signifi cantly different compared with before the intervention ( p < .01).
sessions being performed by the participants. In accordance, we observed 25% -30% improvements in 1RM strength for the LE and LP exercises. This increase in muscle strength is similar to previously published studies ( 17 , 18 , 22 ) . Skeletal muscle strength has been positively correlated with muscle mass and muscle CSA ( 34 , 35 ) . In accordance, we observed a concomitant increase in leg lean mass (6% ± 1%) and quadriceps CSA (9% ± 1%; Table 2 ). The latter clearly shows the effi cacy of the 12-week exercise program to increase muscle mass and strength in healthy, elderly men. Previous studies by other groups ( 1 -3 ) as well as from our laboratory ( 4 ) have shown that the loss of muscle mass with aging is largely attributed to the specifi c atrophy of Type II muscle fi bers. In the present study, we confi rm a substantially smaller Type II muscle fi ber area when compared with Type I muscle fi bers at baseline in the elderly men ( Table 3 ) . Furthermore, we observed a signifi cantly lower myonuclear and SC content in the Type II versus Type I muscle fi bers prior to intervention ( Figure 2 , Table 4 ). The latter is consistent with our recent fi ndings showing a lower SC content in Type II muscle fi bers in muscle tissue from elderly versus young men ( 4 ) . In the present study, no young control group was included, and Type II muscle fi ber characteristics at baseline could only be compared with Type I muscle fi bers, which were relatively large in the present study. However, the latter was probably due to the lower fi ber circularity as compared with our previous study (0.71 vs 0.74) ( 4 ). In addition, interindividual variability was large in the present study, with fi ber size ranging from 3,700 to 9,000 m m 2 . Despite these fi ndings, specifi c Type II muscle fi ber atrophy was still apparent when the present data were compared with the young control group in our previous study ( 4 ) . Moreover, we ( 4 ) and others ( 33 ) have previously shown that SC content is similar between Type I and Type II muscle fi bers in young adults. Therefore, we argue that the lower fi ber size and SC content of the Type II versus Type I muscle fi bers at baseline in the present study are consistent with and indicative of the specifi c reduction of Type II muscle fi ber size and SC content with aging. Similar fi ber type -specifi c changes in SC content have also been observed in animal studies ( 39 ) . These data might suggest a causal relationship between a decline in myonuclear and/or SC content and muscle fi ber type -specifi c atrophy. The lower number of SCs might be insuffi cient to support myofi ber maintenance and, as such, contribute to the gradual loss of muscle mass with aging ( 39 ) . Reduced neuromuscular activity (due to a more sedentary lifestyle and/or functional disability) and/or impaired neuronal input might represent important factors contributing to the age-related decline in myonuclear and SC number and activity and the associated reduction in muscle fi ber size ( 20 , 40 ) . More research is warranted to elucidate the potential role of the decline in Type II muscle fi ber SC content in the etiology of sarcopenia.
To further investigate the proposed functional relationship between the reduced SC content in the Type II versus Type I muscle fi bers and the accompanying smaller Type II muscle fi ber size in elderly men, it is of substantial clinical relevance to assess whether strategies that induce muscle fi ber hypertrophy are associated with an increase in muscle fi ber SC content. This would provide important novel information, offering new targets for the evaluation of effective nutritional, pharmaceutical, and/or exercise interventions to combat sarcopenia in older adults. Resistance type exercise training has been established as an effective therapeutic strategy to induce muscle hypertrophy in older adults and has been associated with a more pronounced hypertrophy of the Type II muscle fi bers ( 16 -19 ) . The latter is supported by the present fi ndings, as we observed a 28% ± 6% increase in Type II muscle fi ber CSA following 12 weeks of training ( Table 3 ) . Notably, differences in fi ber size between Type I and II muscle fi bers as observed prior to intervention were no longer apparent after completing the exercise intervention program ( Table 3 ).
There has been much discrepancy in the literature on the proposed impact of resistance type exercise training on myonuclear and/or SC content in muscle tissue in older adults ( 9 , 21 -23 ) . The apparent discrepancy is likely attributed to the lack of fi ber type -specifi c data on muscle fi ber hypertrophy/atrophy and the associated changes in myonuclear and/ or SC content. In the present study, the specifi c hypertrophy of Type II muscle fi bers after training was accompanied by a substantial 76% ± 15% increase in Type II muscle fi ber SC content ( Figure 2 , Table 4 ). In addition, the number of myonuclei per Type II muscle fi ber tended to increase from 2.8 ± 0.2 to 3.3 ± 0.3 ( p = .091), whereas the fi ber area per myonucleus was maintained throughout the intervention period ( p = .531; Table 4 ). These fi ndings are in line with the rationale that myofi ber hypertrophy is facilitated by increased translational activity of preexisting myonuclei and/or the incorporation of newly formed myonuclei ( 11 , 41 , 42 ) . Consequently, our fi ndings suggest that the maximum amount of cytoplasm that can be controlled by one myonucleus, referred to as the " myonuclear domain " ceiling ( 23 , 43 ) , was reached during the intervention program. Therefore, SC proliferation and the subsequent incorporation of their differentiated progeny (ie, newly formed myonuclei) was essential to allow further Type II muscle fi ber hypertrophy. In that respect, it was surprising that we only observed a tendency toward an increase in Type II muscle fi ber myonuclear content ( p = .091). However, as described by Petrella and coworkers ( 42 ) in their recent article, the myofi ber response to an exercise program can be highly variable. By using cluster analysis, the authors reported that participants with extreme myofi ber hypertrophy also showed the largest increases in SC content and both myonuclear number and domain size ( 42 ) . In accordance, interindividual variability has an important role in the apparent discrepancy between signifi cant myofi ber hypertrophy and nonsignifi cant changes in myonuclear content and/or domain as observed in the present and previous studies ( 9 , 23 ) . Supposedly, some participants might have relied more heavily on expansion of the myonuclear domain, whereas most participants were able to incorporate new myonuclei. In the present study, we observed a nonsignifi cant 25% ± 12% increase in the number of myonuclei per Type II muscle fi ber. The latter tends to be in line with the 26% increase observed by Petrella and coworkers ( 42 ) . Because only pre-and postintervention biopsy samples were collected, we can only speculate on the proposed time line between an increase in SC number, the incorporation of new myonuclei, and subsequent muscle fi ber hypertrophy. However, in vitro data and rodent studies indicate that an increase in SC number and subsequent incorporation of new myonuclei precedes muscle hypertrophy (reviewed in ( 20 ) ).
Considering the large interindividual variability in the hypertrophy response and the relations between the changes in myofi ber size, SC content, and myonuclear content, it is interesting to speculate which factors might be responsible for the apparent differential responses. Previous research implicated that the myogenic regulatory factors (myogenin, MyoD, myf-5, and MRF4) and various growth agents such as insulin-like growth factor-I, mechano growth factor, and hepatocyte growth factor have a role in the (load-mediated) hypertrophy and in SC activation and/or proliferation and differentiation (reviewed in ( 6 , 44 ) ). However, most data are derived from in vitro and acute in vivo studies and, as such, little is known on the potential role these agents have in the response to prolonged exercise training. However, as we restricted ourselves to the assessment of the impact of exercise training on muscle fi ber characteristics, we can only speculate on this matter. This is the fi rst study to show that the relatively lower Type II muscle fi ber size and SC content in older adults can be specifically enhanced following 3 months of resistance type exercise training. Though the exact signaling pathways leading to SCinduced muscle fi ber hypertrophy as well as the reasons for interindividual response variability in these pathways remain to be elucidated, these fi ndings might open up novel opportunities for evaluating the effi cacy of nutritional, pharmaceutical, and/or exercise-based interventional strategies to counteract the loss of muscle mass, strength, and function with aging.
We conclude that prolonged resistance type exercise training effectively increases muscle mass and strength in healthy, elderly men. The relative Type II muscle fi ber atrophy and the associated lower SC content in Type II versus Type I muscle fi bers in older adults can be reversed by prolonged resistance type exercise training. The latter indicates that muscle tissue in older adults is still capable of inducing SC proliferation, differentiation, and fusion of new myonuclei into existing muscle fi bers, resulting in Type II muscle fi ber hypertrophy.
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